在炎症性肠道疾病期间缺乏SARS-CoV-2混合免疫力
Amin Alirezaylavasani1, Ingrid Marie Egner1, Børresdatter Dahl2
1Department of Immunology, Oslo University Hospital, Oslo, Norway; KG Jebsen Centre for B cell Malignancies, Institute of Clinical Medicine, University of Oslo, Norway; Precision Immunotherapy Alliance, University of Oslo, Oslo, Norway.
Clinical immunology (Orlando, Fla.)
|December 7, 2024
概括
患有炎症性肠病 (IBD) 的患者对COVID-19疫苗和感染的免疫反应发生变化. 突破性感染可以提高抗体水平,但不能提高细胞免疫力,这表明需要针对IBD患者量身定制的疫苗策略.
科学领域:
- 免疫学 免疫学 免疫学
- 病毒学 病毒学
- 胃肠病学 胃肠病学
背景情况:
- 服用免疫抑制剂的炎症性肠病 (IBD) 患者面临严重COVID-19的高风险.
- 了解对SARS-CoV-2疫苗接种和突破性感染 (BTI) 的免疫反应对于这个脆弱群体至关重要.
研究的目的:
- 在接种疫苗后的IBD患者和BTI中调查系统性炎症和对SARS-CoV-2的细胞免疫反应.
- 确定最佳的疫苗策略和疗法,以增强IBD患者的COVID-19免疫力.
主要方法:
- 在IBD患者和健康捐赠者 (HD) 之间对血清和细胞免疫反应的比较分析.
- 疫苗接种后对抗体水平 (抗RBD IgG),记忆B细胞和CD8 T细胞反应的评估以及BTI.
主要成果:
- 与HD相比,IBD患者在第三剂疫苗接种后的血清反应率较低,抗体减弱速度更快.
- 突破性感染增加了IBD患者的抗RBDIgG和Spike特异性记忆B细胞.
- 细胞免疫反应在BTI后没有显著增强;相反,SARS-CoV-2特异性和旁观者CD8 T细胞被激活.
结论:
- 在IBD的慢性炎症复杂化了对SARS-CoV-2的免疫反应.
- 需要量身定制的疫苗方案和抗炎疗法来改善IBD患者对SARS-CoV-2的细胞免疫力.
相关概念视频
Inflammatory Bowel Disease II: Crohn's Disease
184
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
184
Immunodeficiency Diseases
903
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
There are three main causes of immunodeficiency...
903
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
316
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
316
Chronic Bowel Disorders: Introduction
386
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
386
Inflammatory Bowel Disease I: Ulcerative Colitis
137
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
137
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
142
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
142


